Skip to content
Search

Latest Stories

PSNC publish pharmacy representation progress update and a toolkit for LPCs

The Pharmaceutical Services Negotiating Committee (PSNC) has published an update on the work it is doing as part of the Transforming Pharmacy Representation (TAPR) Programme to take forward the mandate from contractors to deliver the Review Steering Group (RSG) recommendations.

The update is primarily aimed at LPCs – with whom PSNC has been working closely on some of the TAPR work over the summer.


The TAPR Programme is being undertaken in support of PSNC’s work to address the severe challenges facing the community pharmacy sector at present.

Alongside ongoing negotiations with Government and the NHS, two of the TAPR workstreams – focusing on Vision and Strategy, and on Influencing and Negotiation – are essential to supporting CPCF negotiations.

“The workstreams are looking at the future of community pharmacy and how best to persuade policymakers to implement a shared vision, with their objective being to put the sector in a stronger position going into future CPCF negotiations,” said PSNC.

“Other TAPR workstreams are being taken forward to enhance governance and to support the LPCs to make changes, with the ultimate aim that contractors should have a better relationship with, and more oversight of, stronger national and local negotiators in the future.”

As part of PSNC’s support for LPCs to make the changes set out by the RSG, earlier this week it held two online sessions with LPCs.

The committee has also published Phase 1 of an LPC Toolkit. “Contractors can expect to hear from LPCs about discussions on possible changes at LPC level in the autumn.”

The update provides an overview of all of this work, giving a description of each of the TAPR Programme workstreams and milestones.

PSNC chief executive Janet Morrison said: “Community pharmacy contractors are facing immense challenges at the moment and everyone at PSNC is working tirelessly and with a sharp focus on getting them the help they so urgently need. But as well as making the case for short-term support on things like energy bills, we must also have an eye to the long-term sustainability of the sector: it has always been my view that the bigger prize for the sector is what comes after the current five-year CPCF.

Through the TAPR Programme work we are beginning to prepare for that longer-term future, working hard to put PSNC, the LPCs and ultimately the community pharmacy sector in a stronger position for future negotiations.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less